Emmerthal, Germany

Holger Ott

This inventor holds 1 USPTO granted patent. Top assignee: Lomapharm, Rudolf Lohmann Gmbh Kg, Pharmazeutische Fabrik. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Holger Ott. Retrieved from https://idiyas.com/inventor/holger-ott

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Holger Ott: Innovator in Immunostimulating Polysaccharides

Introduction

Holger Ott is an innovative inventor based in Emmerthal, Germany, recognized for his contribution to the field of immunology through his work with plant polysaccharides. His research focuses on the interaction of these polysaccharides with the immune system, leading to significant advancements in medical applications.

Latest Patents

Holger Ott holds a patent for "Immunostimulating polysaccharides, method for using such." This invention pertains to plant polysaccharides that affect the immune system and outlines a process for isolating these polysaccharides from plant cell cultures. The purified polysaccharides have the potential to be utilized as drugs, specifically as immunomodulators or immune mediators in animal medicine.

Career Highlights

He is affiliated with Lomapharm, Rudolf Lohmann GmbH KG, a prominent pharmaceutical company. In his role, he has been instrumental in developing formulations that leverage the immune-modulating properties of plant-derived substances.

Collaborations

Holger collaborates with esteemed colleagues, including Hildebert Wagner and Meinhart H. Zenk. Their combined expertise in the field of pharmaceutical sciences enhances the research and development processes at Lomapharm.

Conclusion

Holger Ott's commitment to innovation in immunology is evident through his patent and collaborative endeavors. His work not only contributes to advancements in animal medicine but also holds promise for future applications in human health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…